Stockreport

ANIP Q3 Deep Dive: Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook [Yahoo! Finance]

ANI Pharmaceuticals, Inc.  (ANIP) 
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am Check Earnings Report
PDF The company's full-year revenue guidance of $863.5 million at the midpoint came in 1.8% above analysts' estimates. Its non-GAAP profit of $2.04 per share was 15.2% above [Read more]